Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details - Stock warrants activity)

v3.24.3
STOCKHOLDERS' EQUITY (Details - Stock warrants activity) - Common Stock Warrants [Member]
 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Shares outstanding, Beginning | shares 7,041
Weighted average exercise price outstanding, Beginning | $ / shares $ 2,551.75
Shares outstanding, Granted | shares 348,335
Weighted average exercise price outstanding, Granted | $ / shares $ 38.57
Shares outstanding, Canceled | shares 0
Weighted average exercise price outstanding, Canceled | $ / shares $ 0
Shares outstanding, Expired | shares 0
Weighted average exercise price outstanding, Expired | $ / shares $ 0
Shares outstanding, Exercised | shares (259,579)
Weighted average exercise price outstanding, Exercised | $ / shares $ 51.83
Shares outstanding, Ending | shares 95,797
Weighted average exercise price outstanding, Ending | $ / shares $ 187.35
Weighted average remaining life in years, Outstanding 4 years 9 months 25 days
Intrinsic value, Outstanding | $ $ 683,107
Shares outstanding, Exercisable | shares 83,111
Weighted average exercise price outstanding, Exercisable | $ / shares $ 180.54
Weighted average remaining life in years, Exercisable 4 years 9 months 7 days
Intrinsic value, Exercisable | $ $ 683,107